Advanced Medical Solutions Group Plc · LSE:AMS
Advanced Medical Solutions — Shareholder Meeting (May 2013)
9 slides from Advanced Medical Solutions's shareholder meeting presentation, May 22, 2013
Slide 1: Annual General Meeting
Annual General Meeting 22nd May 2013
Slide 2: 2012 financial highlights
2012 financial highlights – Group revenue up 53% to £52.6 million (2011: £34.4 million) – Adjusted2 profit before tax up 85% to £12.1 million (2011: £6.6 million) – Adjusted2 fully diluted earnings per share up 24% to 5.30p (2011: 4.28p) – Net debt3 reduced to £5.5 million (2011: £13.4 million) – Pr
Slide 3: Business unit organisation
Business unit organisation Branded White Label Unit Direct Distributed OEM Bulk Materials Global network Direct sales teams in Global advanced Convertors, packers, of >100 distribution Route-to-market Germany, UK & Czech woundcare customer advanced woundcare partners (including Republic base partner
Slide 4: Branded Direct: 2012 progress
Branded Direct: 2012 progress £20.1m (2011: £5.7m) – ActivHeal (revenue up 29%) – Cost savings without compromise on clinical effectiveness – Continued good progress supported by clinical education programme – RESORBA (revenue up 5%) – UK tender awards for sutures and haemostats – LiquiBand UK (r
Slide 5: Branded Distributed: 2012 progress
Branded Distributed: 2012 progress £6.8m (2011: £3.6m) – LiquiBand US – Excellent progress in Alternate Site sector – Market share by volume increased to 13% – Distribution channels being extended in Acute (hospital) sector resulting from partner not meeting minima – Market share by volume fell to
Slide 6: OEM: 2012 Progress
OEM: 2012 Progress £22.0m (2011: £18.5m) – Continued progress with silver alginate – Revenues up 22% – Progress across EU and UK as well as US – Upgrade launched in Q4 2012 – reinforced dressings – Trilaminate foam launched – Orders in place for 2013 sales 6
Slide 7: Bulk Materials: 2012 progress
Bulk Materials: 2012 progress £3.8m (2011: £6.6m) – Difficult year for bulk foam as flagged a year ago – Pipeline filling from customers’ product launches impacted revenue – Revenue growth in 2013 already visible – Solid new customer pipeline activity for both bulk foam and alginates 7
Slide 8: Organisation
Organisation – Business Unit Heads appointed and in place – General Manager appointed and in place for German and Czech plants – Strengthened Group Quality and Regulatory function with new head who started on 1 May 2013 – Board to be strengthened with appointment of new Non-Executive Director with r
Slide 9: Summary & Outlook
Summary & Outlook – Enlarged Group has been restructured to exploit future growth opportunities and deliver on RESORBA acquisition synergies – Distribution routes for LiquiBand in the US to be expanded with new partners and products in the pipeline – ActivHeal, silver alginate and US LiquiBand A
Advanced Medical Solutions Group — Shareholder Meeting (May 2013) on 6ix